Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer

Int J Nanomedicine. 2019 Feb 15:14:1241-1254. doi: 10.2147/IJN.S189688. eCollection 2019.

Abstract

Background: Traditional intravesical instillation treatment in bladder cancer has limited efficacy, which results in a high frequency of recurrence.

Purpose: The aim of this study was to report on an epirubicin (EPI)-loaded magnetic multi-walled carbon nanotube (mMWCNTs-EPI) system for intravesical instillation in place of the current formulation.

Methods: The mMWCNTs-EPI system was formulated with carboxylated MWCNTs, Fe3O4 magnetic nanoparticles, and EPI. Features and antitumor activity of the system were investigated.

Results: Under the effect of external magnets, the mMWCNTs-EPI system showed sustained release and prolonged retention behavior and better antitumor activity than free EPI. The mMWCNTs-EPI system had higher efficiency in enhancing cytotoxicity and inhibiting proliferation in vitro and in vivo than free EPI. Our studies also revealed the atoxic nature of mMWCNTs.

Conclusion: These findings suggested that mMWCNTs are effective intravesical instillation agents with great potential for clinical application.

Keywords: carbon nanotubes; epirubicin; intravesical drug delivery; intravesical instillation.

MeSH terms

  • Administration, Intravesical
  • Animals
  • Antibiotics, Antineoplastic / pharmacology
  • Antibiotics, Antineoplastic / therapeutic use
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Delayed-Action Preparations
  • Epirubicin / administration & dosage*
  • Epirubicin / pharmacology
  • Epirubicin / therapeutic use*
  • Female
  • Humans
  • Ki-67 Antigen / metabolism
  • Magnetics*
  • Male
  • Nanotubes, Carbon / chemistry*
  • Nanotubes, Carbon / toxicity
  • Nanotubes, Carbon / ultrastructure
  • Rats
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Antibiotics, Antineoplastic
  • Delayed-Action Preparations
  • Ki-67 Antigen
  • Nanotubes, Carbon
  • Epirubicin